A new threat from an old enemy: Re‑emergence of coronavirus (Review)
- Authors:
- Anca Oana Docea
- Aristidis Tsatsakis
- Dana Albulescu
- Oana Cristea
- Ovidiu Zlatian
- Marco Vinceti
- Sterghios A. Moschos
- Dimitris Tsoukalas
- Marina Goumenou
- Nikolaos Drakoulis
- Josef M. Dumanov
- Victor A. Tutelyan
- Gennadii G. Onischenko
- Michael Aschner
- Demetrios A. Spandidos
- Daniela Calina
-
Affiliations: Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece, Department of Radiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Microbiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, I‑41125 Modena, Italy, Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle‑Upon‑Tyne NE1 8ST, UK, Metabolomic Medicine, Health Clinics for Autoimmune and Chronic Diseases, 10674 Athens, Greece, Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece, Mycological Institute US EU, Subclinical Research Group, Sparta, NJ 07871, USA, Russian Academy of Sciences, 119991 Moscow, Russia, The State Education Institution of Higher Professional Training, The First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation, 119992 Moscow, Russia, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania - Published online on: March 27, 2020 https://doi.org/10.3892/ijmm.2020.4555
- Pages: 1631-1643
-
Copyright: © Docea et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Groot RJ, Baker SC, Baric R, et al: Family - Coronaviridae. Virus Taxonomy Ninth Report of the International Committee on Taxonomy of Viruses King AMQ. Lefkowitz EJ, Adams MJ and Carstens EB: Elsevier; pp. 806–828. 2011 | |
van Doremalen N, Bushmaker T, Morris DH, et al: Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. Mar 17–2020.Epub ahead of print. View Article : Google Scholar : | |
Geller C, Varbanov M and Duval RE: Human coronaviruses: Insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses. 4:3044–3068. 2012. View Article : Google Scholar : PubMed/NCBI | |
Anthony SJ, Johnson CK, Greig DJ, Kramer S, Che X, Wells H, Hicks AL, Joly DO, Wolfe ND, Daszak P, et al: PREDICT Consortium: Global patterns in coronavirus diversity. Virus Evol. 3:vex0122017. View Article : Google Scholar | |
Goumenou M, Spandidos DA and Tsatsakis A: [Editorial] Possibility of transmission through dogs being a contributing factor to the extreme Covid 19 outbreak in North Italy. Mol Med Rep. In Press. | |
World Health Organization: Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. https://www.who.int/csr/sars/country/table2004_04_21/en/. Accesed July 24, 2015. | |
World Health Organization: Middle East respiratory syndrome coronavirus (MERS-CoV). MERS Monthly Summary. 2013, https://www.who.int/emergencies/mers-cov/en/. Accessed July 9, 2013. | |
World Health Organization: Coronavir us disease (COVID-2019) situation reports. https://www.who.int/emer-gencies/diseases/novel-coronavirus-2019/situation-reports. | |
Movert E, Wu Y, Lambeau G, Kahn F, Touqui L and Areschoug T: Using Patient Pathways to Accelerate the Drive to Ending Tuberculosis. J Infect Dis. 208:2025–2035. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chan-Yeung M and Xu RH: SARS: Epidemiology. Respirology. 8(Suppl): S9–S14. 2003. View Article : Google Scholar | |
Xu RH, He JF, Evans MR, Peng GW, Field HE, Yu DW, Lee CK, Luo HM, Lin WS, Lin P, et al: Epidemiologic clues to SARS origin in China. Emerg Infect Dis. 10:1030–1037. 2004. View Article : Google Scholar : PubMed/NCBI | |
Mobaraki K and Ahmadzadeh J: Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: A cross-sectional study. BMC Infect Dis. 19:3512019. View Article : Google Scholar : PubMed/NCBI | |
Chen N, Zhou M, Dong X, et al: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 395:507–513. 2020. View Article : Google Scholar : PubMed/NCBI | |
Livingston E and Bucher K: Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. Mar 17–2020.Epub ahead of print. View Article : Google Scholar | |
Novel coronavirus (COVID-19) situation. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd. | |
Remuzzi A and Remuzzi G: COVID-19 and Italy: what next? Lancet. Mar 13–2020.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI | |
Lv L, Li G, Chen J, Liang X and Li Y: Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13. bioRxiv. In Press. | |
Pradhan P, Pandey AK, Mishra A, et al: Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. bioRxiv. In Press. | |
Ren LL, Wang YM, Wu ZQ, et al: Identification of a novel coro-navirus causing severe pneumonia in human: a descriptive study. Chin Med J. Feb 11–2020.Epub ahead of print. View Article : Google Scholar | |
Fan Y, Zhao K, Shi ZL and Zhou P: Bat Coronaviruses in China. Viruses. 11:2102019. View Article : Google Scholar : | |
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579:270–273. 2020. View Article : Google Scholar : PubMed/NCBI | |
Leroy EM, Rouquet P, Formenty P, et al: Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife. Science. 303:387–390. 2004. View Article : Google Scholar : PubMed/NCBI | |
Li W, Wong SK, Li F, Kuhn JH, Huang IC, Choe H and Farzan M: Animal origins of the severe acute respiratory syndrome coronavirus: Insight from ACE2-S-protein interactions. J Virol. 80:4211–4219. 2006. View Article : Google Scholar : PubMed/NCBI | |
Drosten C, Günther S, Preiser W, et al: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 348:1967–1976. 2003. View Article : Google Scholar : PubMed/NCBI | |
Lam TTY, Shum MHH, Zhu HC, et al: Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. bioRxiv. In Press. | |
Liu P, Jiang JZ, Hua Y, et al: Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV)? bioRxiv. In Press. | |
Zhang T, Wu Q and Zhang Z: Pangolin homology associated with 2019-nCoV. bioRxiv. In Press. | |
Wang LF and Cowled C: Bats and Viruses: A New Frontier of Emerging Infectious Diseases. John Wiley & Sons Inc; 2015, https://doi.org/10.1002/9781118818824. View Article : Google Scholar | |
Guan Y, Zheng BJ, He YQ, et al: Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science. 302:276–278. 2003. View Article : Google Scholar : PubMed/NCBI | |
Huang C, Wang Y, Li X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020. View Article : Google Scholar : PubMed/NCBI | |
Smiley Evans T, Tutaryebwa L, Gilardi KV, Barry PA, Marzi A, Eberhardt M, Ssebide B, Cranfield MR, Mugisha O, Mugisha E, et al: Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda. J Infect Dis. 218(Suppl 5): S277–S286. 2018. View Article : Google Scholar : PubMed/NCBI | |
Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM and Madani TA: Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 370:2499–2505. 2014. View Article : Google Scholar : PubMed/NCBI | |
Haagmans BL, Al Dhahiry SH, Reusken CB, et al: Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 14:140–145. 2014. View Article : Google Scholar | |
Du L, He Y, Zhou Y, Liu S, Zheng BJ and Jiang S: The spike protein of SARS-CoV - a target for vaccine and therapeutic development. Nat Rev Microbiol. 7:226–236. 2009. View Article : Google Scholar : PubMed/NCBI | |
Li F: Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits. J Virol. 86:2856–2858. 2012. View Article : Google Scholar : | |
Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL and Bates P: Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A. 102:11876–11881. 2005. View Article : Google Scholar : PubMed/NCBI | |
Narayanan K, Huang C and Makino S: SARS coronavirus accessory proteins. Virus Res. 133:113–121. 2008. View Article : Google Scholar | |
Schoeman D and Fielding BC: Coronavirus envelope protein: Current knowledge. Virol J. 16:692019. View Article : Google Scholar : PubMed/NCBI | |
Liu C, Zhou Q, Li Y, et al: Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Cent Sci. 6:315–331. 2020. View Article : Google Scholar : PubMed/NCBI | |
Hoffmann M, Kleine-Weber H, Schroeder S, et al: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Article SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 181:1–10. 2020. View Article : Google Scholar | |
Jeffers SA, Tusell SM, Gillim-Ross L, et al: CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA. 101:15748–15753. 2004. View Article : Google Scholar : PubMed/NCBI | |
Leung WK, To KF, Chan PK, et al: Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 125:1011–1017. 2003. View Article : Google Scholar : PubMed/NCBI | |
Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W and Hao P: Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 63:457–460. 2020. View Article : Google Scholar : PubMed/NCBI | |
Luo C, Luo H, Zheng S, Gui C, Yue L, Yu C, Sun T, He P, Chen J, Shen J, et al: Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun. 321:557–565. 2004. View Article : Google Scholar : PubMed/NCBI | |
Wang C, Horby PW, Hayden FG and Gao GF: A novel coronavirus outbreak of global health concern. Lancet. 395:470–473. 2020. View Article : Google Scholar : PubMed/NCBI | |
Kuba K, Imai Y, Rao S, et al: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 11:875–879. 2005. View Article : Google Scholar : PubMed/NCBI | |
Fred Hutchinson Cancer Research Center: INTERIM guidelines for COVID-19 management in hematopoietic cell transplant and cellular therapy patients, Version 1, 2020. https://www.fredhutch.org/content/dam/www/coronavirus/COVID-19_Interim_Patient_Guidelines_3_9_20.pdf. Accessed March 8 2020. | |
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G and Tan W: Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. Mar 11–2020.Epub ahead of print. View Article : Google Scholar | |
Fang L, Karakiulakis G and Roth M: Are patients with hyper-tension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2600:301162020. | |
Kui L, Fang YY, Deng Y, et al: Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). Feb 7–2020.Epub ahead of print. | |
Qinfen Z, Jinming C, Xiaojun H, et al: The life cycle of SARS coronavirus in Vero E6 cells. J Med Virol. 73:332-7. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ding Y, He L, Zhang Q, et al: Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 203:622–630. 2004. View Article : Google Scholar : PubMed/NCBI | |
Watkins J: Preventing a covid-19 pandemic. BMJ. 368:m8102020. View Article : Google Scholar : PubMed/NCBI | |
Gruber-Bzura BM: Vitamin D and Influenza-Prevention or Therapy? Int J Mol Sci. 19:24192018. View Article : Google Scholar | |
Lau EH, Hsiung CA, Cowling BJ, Chen CH, Ho LM, Tsang T, Chang CW, Donnelly CA and Leung GM: A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan. BMC Infect Dis. 10:502010. View Article : Google Scholar : PubMed/NCBI | |
Guan W, Ni Z, Hu Y, et al: Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. Feb 28–2020.Epub ahead of print. View Article : Google Scholar | |
Ng DL, Al Hosani F, Keating MK, et al: Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates. Am J Pathol. 186:652–658. 2016. View Article : Google Scholar : PubMed/NCBI | |
Alsaad KO, Hajeer AH, Al Balwi M, et al: Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology. 72:516–524. 2018. View Article : Google Scholar | |
Shah K, Bentley E, Tyler A, Richards KSR, Wright E, Easterbrook L, Lee D, Cleaver C, Usher L, Burton JE, et al: Field-deployable, quantitative, rapid identification of active Ebola virus infection in unprocessed blood. Chem Sci (Camb). 8:7780–7797. 2017. View Article : Google Scholar | |
World Health Organization: Country & Technical Guidance - Coronavirus disease (COVID-19). https://www.who.int/emer-gencies/diseases/novel-coronavirus-2019/technical-guidance. | |
Du Z, Xu X, Wu Y, Wang L, Cowling BJ and Meyers LA: Serial Interval of COVID-19 Among Publicly Reported Confirmed Cases. Emerg Infect Dis. Mar 19–2020.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI | |
Crisanti A and Cassone A: In one Italian town, we showed mass testing could eradicate the coronavirus Opinion. The Guardian; 2020, https://www.theguardian.com/comment-isfree/2020/mar/20/eradicated-coronavirus-mass-testing-covid-19-italy-vo. Accessed March 20 2020. | |
Chiu WK, Cheung PC, Ng KL, et al: Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. Pediatr Crit Care Med. 4:279–283. 2003. View Article : Google Scholar : PubMed/NCBI | |
Donnelly CA, Ghani AC, Leung GM, et al: Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 361:1761–1766. 2003. View Article : Google Scholar : PubMed/NCBI | |
Leung GM, Hedley AJ, Ho LM, et al: The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 141:662–673. 2004. View Article : Google Scholar : PubMed/NCBI | |
Booth CM, Matukas LM, Tomlinson GA, et al: Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 289:2801–2809. 2003. View Article : Google Scholar : PubMed/NCBI | |
Chan JW, Ng CK, Chan YH, et al: Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 58:686–689. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hon KL, Leung CW, Cheng WT, et al: Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 361:1701–1703. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hui DS and Sung JJ: Severe acute respiratory syndrome. Chest. 124:12–15. 2003. View Article : Google Scholar : PubMed/NCBI | |
Assiri A, McGeer A, Perl TM, et al: KSA MERS-CoV Investigation Team, 2013b. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 369:407–416. 2013. View Article : Google Scholar : PubMed/NCBI | |
Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al: Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 13:752–761. 2013. View Article : Google Scholar : PubMed/NCBI | |
Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA and Stephens GM: Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 368:2487–2494. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ki M: 2015 MERS Outbreak in Korea: Hospital-To-Hospital Transmission. Epidemiol Heal. 37:e20150332015. View Article : Google Scholar | |
Arabi YM, Balkhy HH, Hayden FG, et al: Middle East Respiratory Syndrome. N Engl J Med. 376:584–594. 2017. View Article : Google Scholar : PubMed/NCBI | |
Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M and Talbot PJ: Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 194:145–158. 2014. View Article : Google Scholar : PubMed/NCBI | |
Saad M, Omrani AS, Baig K, et al: Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 29:301–306. 2014. View Article : Google Scholar : PubMed/NCBI | |
Al-Hameed FM: Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus. Saudi Med J. 38:196–200. 2017. View Article : Google Scholar : PubMed/NCBI | |
Algahtani H, Subahi A and Shirah B: Neurological complications of Middle East respiratory syndrome coronavirus: A report of two cases and review of the literature. Case Rep Neurol Med. 2016:35026832016.PubMed/NCBI | |
Kim JE, Heo JH, Kim HO, et al: Neurological Complications during Treatment of Middle East Respiratory Syndrome. J Clin Neurol. 13:227–233. 2017. View Article : Google Scholar : PubMed/NCBI | |
Cha RH, Yang SH, Moon KC, et al: A Case Report of a Middle East Respiratory Syndrome Survivor with Kidney Biopsy Results. J Korean Med Sci. 31:635–640. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lu H, Stratton CW and Tang YW: Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 92:401–402. 2020. View Article : Google Scholar : PubMed/NCBI | |
Hui DS, Azhar I, Madani E, et al: The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 91:264–266. 2020. View Article : Google Scholar : PubMed/NCBI | |
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG and Lessler J: The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. Mar 10–2020.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI | |
Lin X, Gong Z, Xiao Z, Xiong J, Fan B and Liu J: Novel Coronavirus Pneumonia Outbreak in 2019: Computed Tomographic Findings in Two Cases. Korean J Radiol. 21:365–368. 2020. View Article : Google Scholar : PubMed/NCBI | |
Warren TK, Wells J, Panchal RG, et al: Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 508:402–405. 2014. View Article : Google Scholar : PubMed/NCBI | |
Pan Y, Guan H, Zhou S, et al: Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. Feb 13–2020.Epub ahead of print. View Article : Google Scholar | |
Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L, et al: Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology. Feb 13–2020.Epub ahead of print. View Article : Google Scholar | |
Zheng YY, Ma YT, Zhang JY and Xie X: COVID-19 and the cardiovascular system. Nat Rev Cardiol. Mar 5–2020.Epub ahead of print. View Article : Google Scholar | |
Sung JJ, Wu A, Joynt GM, et al: Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax. 59:414–420. 2004. View Article : Google Scholar : PubMed/NCBI | |
Chu CM, Cheng VC, Hung IF, et al: Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 59:252–256. 2004. View Article : Google Scholar : PubMed/NCBI | |
Loutfy MR, Blatt LM, Siminovitch KA, et al: Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA. 290:3222–3228. 2003. View Article : Google Scholar : PubMed/NCBI | |
Tsui PT, Kwok ML, Yuen H and Lai ST: Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis. 9:1064–1069. 2003. View Article : Google Scholar : PubMed/NCBI | |
Cheng Y, Wong R, Soo YO, et al: Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 24:44–46. 2005. View Article : Google Scholar | |
Omrani AS, Saad MM, Baig K, et al: Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 14:1090–1095. 2014. View Article : Google Scholar : PubMed/NCBI | |
Widagdo W, Okba NMA, Stalin Raj V and Haagmans BL: MERS-coronavirus: From discovery to intervention. One Heal. 3:11–16. 2016. View Article : Google Scholar | |
Calina D, Rosu L, Rosu AF, et al: Etiological diagnosis and pharmacotherapeutic management of parapneumonic pleuresy. Farmacia. 64:946-52. 2016. | |
Cowling BJ, Lam TTY, Yen HL, Poon LLM and Peiris M: Evidence-Based Options for Controlling Respiratory Virus Transmission. Emerg Infect Dis. 23:1712312017. View Article : Google Scholar | |
Zhao Z, Zhang F, Xu M, et al: Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 52:715–720. 2003. View Article : Google Scholar : PubMed/NCBI | |
Al-Qahtani AA, Lyroni K, Aznaourova M, et al: Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. Oncotarget. 8:9053–9066. 2017. View Article : Google Scholar : PubMed/NCBI | |
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B and Park SJ: Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: The Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. J Korean Med Sci. 35:e792020. View Article : Google Scholar : PubMed/NCBI | |
Agostini ML, Andres EL, Sims AC, et al: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio. 9:e00221–18. 2018. View Article : Google Scholar : PubMed/NCBI | |
Cho A, Saunders OL, Butler T, et al: Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett. 22:2705-7. 2012. View Article : Google Scholar | |
Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, et al: Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 9:36532017. View Article : Google Scholar | |
Sun ML, Yang JM, Sun YP and Su GH: Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:142020. | |
Colson P, Rolain JM, Lagier JC, Brouqui P and Raoult D: Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. Mar 4–2020.Epub ahead of print. View Article : Google Scholar | |
Gao J, Tian Z and Yang X: Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 asso-ciated pneumonia in clinical studies. Biosci Trends. 14:72–73. 2020. View Article : Google Scholar : PubMed/NCBI | |
Clinical Trials Arena: ROCHE to start Phase III trial of Actemra in Covid-19 patients. https://www.clinicaltrialsarena.com/news/roche-actemra-covid-19-trial/. Accessed March 19 2020. | |
Healio: Sarilumab enters clinical trial for COVID-19, spotlighting 'key role' for IL-6. https://www.healio.com/rheu-matology/rheumatoid-arthritis/news/online/%7B1957db6e-f7a2-4e5d-939e-d4b5964b2dd3%7D/sarilumab-enters-clinical-trial-for-covid-19-spotlighting-key-role-for-il-6. Accessed March 19, 2020. | |
Zhitomirsky B and Assaraf YG: Lysosomes as mediators of drug resistance in cancer. Drug Resist Updat. 24:23–33. 2016. View Article : Google Scholar : PubMed/NCBI | |
Kazmi F, Hensley T, Pope C, Funk RS, Loewen GJ, Buckley DB and Parkinson A: Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug Metab Dispos. 41:897–905. 2013. View Article : Google Scholar : PubMed/NCBI | |
Adar Y, Stark M, Bram EE, Nowak-Sliwinska P, van den Bergh H, Szewczyk G, Sarna T, Skladanowski A, Griffioen AW and Assaraf YG: Imidazoacridinone-dependent lysosomal photodestruction: A pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death Dis. 3:e293. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ashfaq UA, Javed T, Rehman S, Nawaz Z and Riazuddin S: Lysosomotropic agents as HCV entry inhibitors. Virol J. 8:1632011. View Article : Google Scholar : PubMed/NCBI | |
Kaufmann AM and Krise JP: Lysosomal sequestration of amine-containing drugs: Analysis and therapeutic implications. J Pharm Sci. 96:729–746. 2007. View Article : Google Scholar | |
WHO: SARS risk assessment and preparedness framework. 2004, https://www.who.int/csr/resources/publications/CDS_CSR_ARO_2004_2.pdf. | |
Craven J: COVID-19 Vaccine Tracker. Regulatory Affairs Professionals Society (RAPS); 2020, https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker. Accessed March 21, 2020. | |
Martin JE, Louder MK, Holman LA, et al: VRC 301 Study Team. Vaccine. 26:6338–6343. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lin JT, Zhang JS, Su N, et al: Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine. Antivir Ther. 12:1107–1113. 2007.PubMed/NCBI | |
Beigel JH, Voell J, Kumar P, et al: Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study. Lancet Infect Dis. 18:410–418. 2018. View Article : Google Scholar : PubMed/NCBI | |
Janice Oh HL, Ken-En Gan S, Bertoletti A and Tan YJ: Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect. 1:e232012. View Article : Google Scholar : PubMed/NCBI |